首页 > 最新文献

American Journal of Otolaryngology最新文献

英文 中文
Analysis of head and eye dynamic may explain saccades in dizzy patients with normal VOR gain 头眼动态分析可解释 VOR 增益正常的眩晕患者的眼球运动
IF 1.8 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-26 DOI: 10.1016/j.amjoto.2024.104503
C. Orsini , A.M. Cedras , A. Sam Pierre , J. Dion , M. Maheu

Objective

Compare the vestibulo-ocular reflex (VOR) gain, compensatory saccades and head and eye coordination during head impulses between patients with dizziness but normal VOR gain and healthy controls.

Methods

Video head impulses test (vHIT; ICS impulse, Otometrics, Denmark) was reviewed in 40 participants (20 patients with dizziness; 20 controls). VOR gain, saccades characteristics (frequency of occurrence, amplitude, latency) and time difference between head and eye velocity was compared.

Results

No significant difference between groups was observed for VOR gain. However, saccade frequency was greater and time difference between head and eye was prolonged in patients with dizziness. No significant difference was observed for saccade amplitude, nor for saccade latency between groups.

Conclusions

The present study highlights that saccades observed in patients with normal VOR gain could reflect a clinical marker for dizziness in patients with normal VOR gain. We propose that theses saccades are caused by a prolonged time delay between head and eye velocity leading to a gaze position error.

Significance

The results support previous findings suggesting additional value of saccades and time delay when interpreting vHIT results. This study goes further by proposing time delay as a possible mechanism to explain increased saccade frequency in dizzy patients with normal VOR gain.

目的 比较头晕但 VOR 增益正常的患者与健康对照组在头部冲动时的前庭-眼反射(VOR)增益、代偿性眼球移动和头眼协调情况。方法 对 40 名参与者(20 名头晕患者;20 名对照组)进行视频头部冲动测试(vHIT;ICS impulse,Otometrics,丹麦)。比较了VOR增益、囊回特性(发生频率、振幅、潜伏期)以及头眼速度的时间差。然而,眩晕患者的囊回频率更高,头眼速度时间差更长。结论 本研究强调,在 VOR 增益正常的患者中观察到的囊状移动可反映出头晕的临床标记。我们认为,这些眼球移动是由于头部和眼球速度之间的时间延迟过长导致注视位置错误所致。研究结果支持了之前的研究结果,即在解释 vHIT 结果时,眼球移动和时间延迟具有额外的价值。本研究进一步提出,时间延迟是解释VOR增益正常的眩晕患者囊回频率增加的可能机制。
{"title":"Analysis of head and eye dynamic may explain saccades in dizzy patients with normal VOR gain","authors":"C. Orsini ,&nbsp;A.M. Cedras ,&nbsp;A. Sam Pierre ,&nbsp;J. Dion ,&nbsp;M. Maheu","doi":"10.1016/j.amjoto.2024.104503","DOIUrl":"10.1016/j.amjoto.2024.104503","url":null,"abstract":"<div><h3>Objective</h3><p>Compare the vestibulo-ocular reflex (VOR) gain, compensatory saccades and head and eye coordination during head impulses between patients with dizziness but normal VOR gain and healthy controls.</p></div><div><h3>Methods</h3><p>Video head impulses test (vHIT; ICS impulse, Otometrics, Denmark) was reviewed in 40 participants (20 patients with dizziness; 20 controls). VOR gain, saccades characteristics (frequency of occurrence, amplitude, latency) and time difference between head and eye velocity was compared.</p></div><div><h3>Results</h3><p>No significant difference between groups was observed for VOR gain. However, saccade frequency was greater and time difference between head and eye was prolonged in patients with dizziness. No significant difference was observed for saccade amplitude, nor for saccade latency between groups.</p></div><div><h3>Conclusions</h3><p>The present study highlights that saccades observed in patients with normal VOR gain could reflect a clinical marker for dizziness in patients with normal VOR gain. We propose that theses saccades are caused by a prolonged time delay between head and eye velocity leading to a gaze position error.</p></div><div><h3>Significance</h3><p>The results support previous findings suggesting additional value of saccades and time delay when interpreting vHIT results. This study goes further by proposing time delay as a possible mechanism to explain increased saccade frequency in dizzy patients with normal VOR gain.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104503"},"PeriodicalIF":1.8,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142122612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating industry payments to editorial board members of otolaryngology journals 评估企业向耳鼻喉科期刊编委会成员支付的费用
IF 1.8 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-16 DOI: 10.1016/j.amjoto.2024.104501
Zaneta N. Harlianto , Netanja I. Harlianto

Objective

To evaluate the extent of payments from medical device and pharmaceutical companies to editorial board members of leading otolaryngology journals.

Methods

Editorial board members of the top 10 otolaryngology journals from Google Scholar rankings were identified in this cross-sectional study.

Payments between 2017 and 2022 were identified via the Open Payments Database from the Centers for Medicare and Medicaid Services. All payment data was adjusted for inflation in 2022 US dollars. Descriptive analyses were performed and journal websites were evaluated for individual editor disclosures.

Results

Out of 581 board members, 306 (53 %) received industry payments between 2017 and 2022, median journal percentage 55 % (interquartile range: 26.5 %–73.5 %). A sum of $45.8 million was paid out between 2017 and 2022, comprising $32.0 million in associated research funding, $1.2 million in research payments, $1.4 million in ownership and investment interests, and $11.2 million in general payments. The largest general payments were made out for “services other than consulting and speaking” ($3.9 million), “consulting” ($3.8 million), “travel and lodging” ($0.99 million), “education” ($0.87 million), “royalty or license” ($0.56 million), and “food and beverage” ($0.55 million). Individual editor disclosures were only available for International Forum of Allergy and Rhinology (9 % of all included editors).

Conclusions

Industry payments to editors of otolaryngology journals are not uncommon. We highlight the need for improved reporting of individual editor disclosures for transparency to journal readers and for minimizing biased editorial decisions.

目的评估医疗设备和制药公司向主要耳鼻喉科期刊编委会成员支付费用的程度。方法在这项横断面研究中确定了谷歌学术排名前 10 位的耳鼻喉科期刊的编委会成员。所有支付数据均按 2022 年美元通胀率进行了调整。结果在581名董事会成员中,有306人(53%)在2017年至2022年期间接受了行业支付,期刊百分比中位数为55%(四分位间范围:26.5%-73.5%)。在 2017 年至 2022 年期间,共支付了 4580 万美元,其中包括 3200 万美元的相关研究经费、120 万美元的研究经费、140 万美元的所有权和投资权益,以及 1120 万美元的一般支付。最大的一般付款用于 "咨询和演讲以外的服务"(390 万美元)、"咨询"(380 万美元)、"差旅和住宿"(99 万美元)、"教育"(87 万美元)、"版税或许可证"(56 万美元)以及 "食品和饮料"(55 万美元)。只有《国际过敏与鼻病论坛》(占所有收录编辑的 9%)的编辑个人披露了相关信息。我们强调有必要改进编辑个人披露信息的报告,以提高期刊读者的透明度,并尽量减少编辑决策的偏差。
{"title":"Evaluating industry payments to editorial board members of otolaryngology journals","authors":"Zaneta N. Harlianto ,&nbsp;Netanja I. Harlianto","doi":"10.1016/j.amjoto.2024.104501","DOIUrl":"10.1016/j.amjoto.2024.104501","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the extent of payments from medical device and pharmaceutical companies to editorial board members of leading otolaryngology journals.</p></div><div><h3>Methods</h3><p>Editorial board members of the top 10 otolaryngology journals from Google Scholar rankings were identified in this cross-sectional study.</p><p>Payments between 2017 and 2022 were identified via the Open Payments Database from the Centers for Medicare and Medicaid Services. All payment data was adjusted for inflation in 2022 US dollars. Descriptive analyses were performed and journal websites were evaluated for individual editor disclosures.</p></div><div><h3>Results</h3><p>Out of 581 board members, 306 (53 %) received industry payments between 2017 and 2022, median journal percentage 55 % (interquartile range: 26.5 %–73.5 %). A sum of $45.8 million was paid out between 2017 and 2022, comprising $32.0 million in associated research funding, $1.2 million in research payments, $1.4 million in ownership and investment interests, and $11.2 million in general payments. The largest general payments were made out for “services other than consulting and speaking” ($3.9 million), “consulting” ($3.8 million), “travel and lodging” ($0.99 million), “education” ($0.87 million), “royalty or license” ($0.56 million), and “food and beverage” ($0.55 million). Individual editor disclosures were only available for International Forum of Allergy and Rhinology (9 % of all included editors).</p></div><div><h3>Conclusions</h3><p>Industry payments to editors of otolaryngology journals are not uncommon. We highlight the need for improved reporting of individual editor disclosures for transparency to journal readers and for minimizing biased editorial decisions.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104501"},"PeriodicalIF":1.8,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0196070924002874/pdfft?md5=e61f1f0a4bd01be2f44b352a910b5408&pid=1-s2.0-S0196070924002874-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142040243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative study of endoscopic underlay myringoplasty with or without tucking of the attached perichondrium graft when repairing large central dry perforations 在修复中央干性大穿孔时,内窥镜下耳膜衬垫成形术有无塞入附着的软骨膜移植物的比较研究
IF 1.8 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-14 DOI: 10.1016/j.amjoto.2024.104471
Jian Yang , Yajian Shen , Chaowei Zhao, Zhengcai Lou

Objective

To compare the graft success rates and hearing outcomes of underlay myringoplasty with or without perichondrium tucking of the attached perichondrium, graft perforation margins when repairing chronic large central dry perforations.

Study design

Randomized controlled trial.

Material and methods

Chronic large central dry perforations were prospectively randomized to tucking perichondrium graft underlay (TPGU) and no-tucking perichondrium graft underlay (NTPG) groups. The graft outcomes and complications were compared between the two groups at 12 months postoperatively.

Results

In total, 61 patients with large central dry perforations were included. All patients completed 12-month follow-ups. Residual perforations occurred in 0.0 % of the TPGU group and in 12.9 % of the NTPG group (P = 0.129), and re-perforations occurred within 6 months in 0.0 % and 3.2 % of the two groups, respectively (P = 0.987). The graft success rates were 100.0 % (30/30) and 83.9 % (26/31) (P = 0.067). No significant between-group differences were observed in terms of preoperative (P = 0.547) or postoperative (P = 0.612) air bone gaps (ABGs) or mean ABG gains (P = 0.597). No graft-related complications were observed in either group during follow-up. No patients exhibited significant graft blunting or medialization; graft lateralization was noted in one patient of the NTPG group.

Conclusions

Endoscopic cartilage with tucking of the attached perichondrium perforation margins during underlay myringoplasty may improve the graft success rate compared to that of the cartilage push-through technique when repairing large central dry perforations; however, the hearing improvements were comparable in the two groups.

研究设计随机对照试验。材料和方法前瞻性地将慢性中央干性大穿孔患者随机分为有褶皱软骨移植垫层组(TPGU)和无褶皱软骨移植垫层组(NTPG)。结果共纳入 61 例中央干性大穿孔患者。所有患者均完成了 12 个月的随访。TPGU组和NTPG组分别有0.0%和12.9%的患者出现残留穿孔(P = 0.129),两组分别有0.0%和3.2%的患者在6个月内出现再次穿孔(P = 0.987)。移植成功率分别为 100.0%(30/30)和 83.9%(26/31)(P = 0.067)。在术前(P = 0.547)或术后(P = 0.612)空气骨间隙(ABG)或平均 ABG 增量(P = 0.597)方面,没有观察到明显的组间差异。两组患者在随访期间均未发现移植物相关并发症。结论与软骨推入技术相比,内窥镜软骨内衬耳轮成形术在修复中央干性大穿孔时收拢附着的软骨周围穿孔边缘可能会提高移植成功率,但两组患者的听力改善效果相当。
{"title":"Comparative study of endoscopic underlay myringoplasty with or without tucking of the attached perichondrium graft when repairing large central dry perforations","authors":"Jian Yang ,&nbsp;Yajian Shen ,&nbsp;Chaowei Zhao,&nbsp;Zhengcai Lou","doi":"10.1016/j.amjoto.2024.104471","DOIUrl":"10.1016/j.amjoto.2024.104471","url":null,"abstract":"<div><h3>Objective</h3><p>To compare the graft success rates and hearing outcomes of underlay myringoplasty with or without perichondrium tucking of the attached perichondrium, graft perforation margins when repairing chronic large central dry perforations.</p></div><div><h3>Study design</h3><p>Randomized controlled trial.</p></div><div><h3>Material and methods</h3><p>Chronic large central dry perforations were prospectively randomized to tucking perichondrium graft underlay (TPGU) and no-tucking perichondrium graft underlay (NTPG) groups. The graft outcomes and complications were compared between the two groups at 12 months postoperatively.</p></div><div><h3>Results</h3><p>In total, 61 patients with large central dry perforations were included. All patients completed 12-month follow-ups. Residual perforations occurred in 0.0 % of the TPGU group and in 12.9 % of the NTPG group (<em>P</em> = 0.129), and re-perforations occurred within 6 months in 0.0 % and 3.2 % of the two groups, respectively (<em>P</em> = 0.987). The graft success rates were 100.0 % (30/30) and 83.9 % (26/31) (<em>P</em> = 0.067). No significant between-group differences were observed in terms of preoperative (<em>P</em> = 0.547) or postoperative (<em>P</em> = 0.612) air bone gaps (ABGs) or mean ABG gains (<em>P</em> = 0.597). No graft-related complications were observed in either group during follow-up. No patients exhibited significant graft blunting or medialization; graft lateralization was noted in one patient of the NTPG group.</p></div><div><h3>Conclusions</h3><p>Endoscopic cartilage with tucking of the attached perichondrium perforation margins during underlay myringoplasty may improve the graft success rate compared to that of the cartilage push-through technique when repairing large central dry perforations; however, the hearing improvements were comparable in the two groups.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104471"},"PeriodicalIF":1.8,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141991236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of laser ablation and microwave ablation to treat papillary thyroid microcarcinoma: A retrospective study 激光消融和微波消融治疗甲状腺乳头状微癌的有效性和安全性:一项回顾性研究
IF 1.8 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-14 DOI: 10.1016/j.amjoto.2024.104496
Yuqing Huang , Xinyu Zhao , Yu Yang , Lanyan Qiu , Junfeng Zhao , Linxue Qian , Xianquan Shi

Objective

To retrospectively analyze the efficacy and safety of laser ablation (LA) and microwave ablation (MWA) in the treatment of papillary thyroid microcarcinoma (PTMC).

Methods

This was a retrospective study of 103 patients (109 nodules) who underwent thermal ablation for PTMC between October 2019 and March 2023; 61 underwent LA and 48 underwent MWA. The mean patients' age was 43.50 ± 12.42 years. After ablation, changes in tumor size at different time points, local recurrence, new lesions, lymph node metastasis, and complications were evaluated and recorded. The feasibility, success rate, and safety of LA and MWA were analyzed.

Results

Complete absence of enhancement on contrast-enhanced ultrasonography was observed in all target tumors after ablation. At the last follow-up, the mean volume of the PTMC nodules decreased from 0.09 ± 0.09 to 0.03 ± 0.03 ml (LA group) and from 0.11 ± 0.10 to 0.06 ± 0.08 ml (MWA group) (both, P < 0.05). There was no significant difference in volume change between the groups (P (groups): 0.520; P (groups over time): 0.423), indicating similar efficacy between the groups. There was also no significant difference in the volume reduction rate between the groups during follow-up, except for at 3 months (P = 0.023). The complication rates did not differ between the LA group (8.2 %) and MWA group (6.3 %) (P > 0.05).

Conclusion

During the short-term follow-up, ultrasound-guided LA and MWA were effective and safe for PTMC, and there were no significant differences in treatment outcomes between the methods.

目的回顾性分析激光消融(LA)和微波消融(MWA)治疗甲状腺乳头状微癌(PTMC)的疗效和安全性。方法这是一项回顾性研究,研究对象为2019年10月至2023年3月期间接受热消融治疗PTMC的103例患者(109个结节),其中61例接受了LA治疗,48例接受了MWA治疗。患者平均年龄为(43.50±12.42)岁。消融术后,对不同时间点的肿瘤大小变化、局部复发、新病灶、淋巴结转移和并发症进行了评估和记录。分析了 LA 和 MWA 的可行性、成功率和安全性。在最后一次随访中,PTMC结节的平均体积从0.09±0.09毫升(LA组)减小到0.03±0.03毫升(MWA组)(均为P< 0.05)。各组之间的血容量变化无明显差异(P(组):0.520;P(组):0.520;P(组):0.520):0.520; P (groups over time):0.423),表明两组疗效相似。在随访期间,除 3 个月外,各组的体积缩小率也无明显差异(P = 0.023)。结论在短期随访中,超声引导 LA 和 MWA 治疗 PTMC 有效且安全,两种方法的治疗效果无明显差异。
{"title":"Efficacy and safety of laser ablation and microwave ablation to treat papillary thyroid microcarcinoma: A retrospective study","authors":"Yuqing Huang ,&nbsp;Xinyu Zhao ,&nbsp;Yu Yang ,&nbsp;Lanyan Qiu ,&nbsp;Junfeng Zhao ,&nbsp;Linxue Qian ,&nbsp;Xianquan Shi","doi":"10.1016/j.amjoto.2024.104496","DOIUrl":"10.1016/j.amjoto.2024.104496","url":null,"abstract":"<div><h3>Objective</h3><p>To retrospectively analyze the efficacy and safety of laser ablation (LA) and microwave ablation (MWA) in the treatment of papillary thyroid microcarcinoma (PTMC).</p></div><div><h3>Methods</h3><p>This was a retrospective study of 103 patients (109 nodules) who underwent thermal ablation for PTMC between October 2019 and March 2023; 61 underwent LA and 48 underwent MWA. The mean patients' age was 43.50 ± 12.42 years. After ablation, changes in tumor size at different time points, local recurrence, new lesions, lymph node metastasis, and complications were evaluated and recorded. The feasibility, success rate, and safety of LA and MWA were analyzed.</p></div><div><h3>Results</h3><p>Complete absence of enhancement on contrast-enhanced ultrasonography was observed in all target tumors after ablation. At the last follow-up, the mean volume of the PTMC nodules decreased from 0.09 ± 0.09 to 0.03 ± 0.03 ml (LA group) and from 0.11 ± 0.10 to 0.06 ± 0.08 ml (MWA group) (both, <em>P</em> &lt; 0.05). There was no significant difference in volume change between the groups (P (groups): 0.520; P (groups over time): 0.423), indicating similar efficacy between the groups. There was also no significant difference in the volume reduction rate between the groups during follow-up, except for at 3 months (<em>P</em> = 0.023). The complication rates did not differ between the LA group (8.2 %) and MWA group (6.3 %) (<em>P</em> &gt; 0.05).</p></div><div><h3>Conclusion</h3><p>During the short-term follow-up, ultrasound-guided LA and MWA were effective and safe for PTMC, and there were no significant differences in treatment outcomes between the methods.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104496"},"PeriodicalIF":1.8,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142021389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is video interpretation compromising care for the hearing loss population? 视频口译是否会影响对听力损失人群的护理?
IF 1.8 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-14 DOI: 10.1016/j.amjoto.2024.104499
Julianna Mastropierro , Ritwik Sanyal , Alyssa Heiser , Emily Gjini , Kathryn Noonan

Objective

The convergence of hearing impairment and language barriers presents unique communication challenges to patients and practicing otolaryngologists. Limited data exist comparing interpretation methods for patients with hearing loss. Patients with hearing loss rely on visual cues, lip-reading, written communication, and/or comprehensive interaction techniques, which may encounter limitations by remote services. Herein, we examine patient and otolaryngology provider satisfaction, cost, and encounter efficiency between virtual and in-person interpretation among adults who speak Mandarin and Cantonese.

Methods

This study is a prospective, randomized controlled trial in patients with moderate-to-severe bilateral hearing loss, Limited English Proficiency, and a primary language of Mandarin or Cantonese. Fifty-two patients were randomized to either in-person or virtual interpretation conditions. Patient satisfaction was measured using an 8-item Likert scale assessing communication effectiveness, encounter efficiency, and overall quality. Otolaryngology provider satisfaction was measured using a 1-item Likert scale. Encounter time, cost, and communication difficulty were measured and compared using independent sample t-tests.

Results

Patient and otolaryngology provider satisfaction scores were significantly higher with in-person interpretation (p < 0.05 for 7 of 8 patient items; physician mean score 4.9, p < 0.001, r = 0.54) compared to virtual interpretation (physician mean 3.8) conditions, while overall quality of the encounter remained the same. There was no significant difference in the length of encounters or in the number of times patients requested interpreter repetition between groups. A difference in average cost existed for in-person interpretation ($14.50) compared to video interpretation ($25) services for an average length appointment.

Conclusion

Patients and otolaryngologists reported higher overall satisfaction with in-person compared to virtual interpretation services. In-person interpretation yielded better comprehension in the hearing loss population among Mandarin and Cantonese-speaking patients and demonstrated a cost advantage over virtual interpretation.

目的听力障碍和语言障碍交织在一起,给患者和耳鼻喉科医生的沟通带来了独特的挑战。对听力损失患者的口译方法进行比较的数据有限。听力损失患者依赖于视觉提示、读唇、书面交流和/或综合互动技术,这些方法可能会受到远程服务的限制。本研究是一项前瞻性随机对照试验,研究对象为中重度双侧听力损失、英语能力有限且主要语言为普通话或粤语的患者。52 名患者被随机分配到现场或虚拟口译环境中。患者满意度采用 8 项李克特量表来评估沟通效果、会面效率和总体质量。耳鼻喉科医护人员的满意度采用 1 项李克特量表进行测量。结果与虚拟口译(医生平均分为 3.8 分)相比,患者和耳鼻喉科医生对现场口译的满意度得分明显更高(患者 8 个项目中的 7 个项目,p < 0.05;医生平均分为 4.9 分,p < 0.001,r = 0.54),而会诊的整体质量保持不变。两组患者的会诊时间和要求口译员重复翻译的次数没有明显差异。结论患者和耳鼻喉科医生对现场口译服务的总体满意度高于虚拟口译服务。在听力损失人群中,普通话和粤语患者对当面口译的理解能力更强,与虚拟口译相比具有成本优势。
{"title":"Is video interpretation compromising care for the hearing loss population?","authors":"Julianna Mastropierro ,&nbsp;Ritwik Sanyal ,&nbsp;Alyssa Heiser ,&nbsp;Emily Gjini ,&nbsp;Kathryn Noonan","doi":"10.1016/j.amjoto.2024.104499","DOIUrl":"10.1016/j.amjoto.2024.104499","url":null,"abstract":"<div><h3>Objective</h3><p>The convergence of hearing impairment and language barriers presents unique communication challenges to patients and practicing otolaryngologists. Limited data exist comparing interpretation methods for patients with hearing loss. Patients with hearing loss rely on visual cues, lip-reading, written communication, and/or comprehensive interaction techniques, which may encounter limitations by remote services. Herein, we examine patient and otolaryngology provider satisfaction, cost, and encounter efficiency between virtual and in-person interpretation among adults who speak Mandarin and Cantonese.</p></div><div><h3>Methods</h3><p>This study is a prospective, randomized controlled trial in patients with moderate-to-severe bilateral hearing loss, Limited English Proficiency, and a primary language of Mandarin or Cantonese. Fifty-two patients were randomized to either in-person or virtual interpretation conditions. Patient satisfaction was measured using an 8-item Likert scale assessing communication effectiveness, encounter efficiency, and overall quality. Otolaryngology provider satisfaction was measured using a 1-item Likert scale. Encounter time, cost, and communication difficulty were measured and compared using independent sample <em>t</em>-tests.</p></div><div><h3>Results</h3><p>Patient and otolaryngology provider satisfaction scores were significantly higher with in-person interpretation (<em>p</em> &lt; 0.05 for 7 of 8 patient items; physician mean score 4.9, <em>p</em> &lt; 0.001, <em>r</em> = 0.54) compared to virtual interpretation (physician mean 3.8) conditions, while overall quality of the encounter remained the same. There was no significant difference in the length of encounters or in the number of times patients requested interpreter repetition between groups. A difference in average cost existed for in-person interpretation ($14.50) compared to video interpretation ($25) services for an average length appointment.</p></div><div><h3>Conclusion</h3><p>Patients and otolaryngologists reported higher overall satisfaction with in-person compared to virtual interpretation services. In-person interpretation yielded better comprehension in the hearing loss population among Mandarin and Cantonese-speaking patients and demonstrated a cost advantage over virtual interpretation.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104499"},"PeriodicalIF":1.8,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142006720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of antibiotic resistant infections associated with hirudotherapy 与水蛭素疗法相关的抗生素耐药性感染分析
IF 1.8 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-14 DOI: 10.1016/j.amjoto.2024.104500
Philip R. Brauer , Malaak Saadah , Michael A. Fritz , Shannon S. Wu , Eric D. Lamarre

Objective

Given rising concern regarding antibiotic resistance, our objective was to evaluate antibiotic-resistant infections following leech therapy and to characterize the use of prophylactic antibiotics.

Methods

All reports of adverse events involving hirudotherapy (product code “NRN”) were retrieved from the U.S. Food and Drug Administration MAUDE database between 2012 and 2021. Antibiotic resistance was defined by bacterial culture or infection after antibiotic administration.

Results

Nineteen cases of antibiotic resistance involving hirudotherapy were identified. Only three cases of antibiotic resistance were discovered on routine testing and the remaining 16 cases were associated with patient injury. Positive blood cultures or fever were present in 26.3 % (n = 5) of cases. Cultures of the infection grew Aeromonas hydrophilia (n = 13; 68.4 %), Vibrio vulnificus (n = 3; 15.8 %), Pseudomonas aeruginosa (n = 2; 10.5 %), and Proteus vulgaris (n = 1; 5.3 %). There were nine (47.4 %) multi-drug resistant infections. Infection was most commonly resistant to fluoroquinolones (n = 9; 47.4 %), trimethoprim-sulfamethoxazole (n = 9; 47.4 %) and ertapenem (n = 4; 21.1 %).

Conclusion

Antibiotic-resistant infections involving hirudotherapy are frequently resistant to multiple drugs, including fluoroquinolones and trimethoprim-sulfamethoxazole. Resistance to ertapenem, a drug of last resort, was also documented. The findings presented in this study support growing literature that the trend in multi-drug resistance is more severe than previously reported.

方法从美国食品和药物管理局 MAUDE 数据库中检索 2012 年至 2021 年间所有涉及水蛭疗法(产品代码 "NRN")的不良事件报告。抗生素耐药性通过细菌培养或使用抗生素后的感染来定义。结果共发现19例涉及水蛭疗法的抗生素耐药性病例。只有三例抗生素耐药性是在常规检测中发现的,其余 16 例均与患者受伤有关。26.3%的病例(5 例)出现血液培养阳性或发热。感染培养出嗜水气单胞菌(n = 13;68.4%)、弧菌(n = 3;15.8%)、铜绿假单胞菌(n = 2;10.5%)和普通变形杆菌(n = 1;5.3%)。耐多药感染有 9 例(47.4%)。感染最常见的耐药药物是氟喹诺酮类(9 人;47.4%)、三甲双氨-磺胺甲噁唑(9 人;47.4%)和厄他培南(4 人;21.1%)。此外,还发现了对最后一种药物厄他培南的耐药性。越来越多的文献指出,多种药物耐药性的趋势比以往报告的更为严重,本研究的结果支持了这一观点。
{"title":"Analysis of antibiotic resistant infections associated with hirudotherapy","authors":"Philip R. Brauer ,&nbsp;Malaak Saadah ,&nbsp;Michael A. Fritz ,&nbsp;Shannon S. Wu ,&nbsp;Eric D. Lamarre","doi":"10.1016/j.amjoto.2024.104500","DOIUrl":"10.1016/j.amjoto.2024.104500","url":null,"abstract":"<div><h3>Objective</h3><p>Given rising concern regarding antibiotic resistance, our objective was to evaluate antibiotic-resistant infections following leech therapy and to characterize the use of prophylactic antibiotics.</p></div><div><h3>Methods</h3><p>All reports of adverse events involving hirudotherapy (product code “NRN”) were retrieved from the U.S. Food and Drug Administration MAUDE database between 2012 and 2021. Antibiotic resistance was defined by bacterial culture or infection after antibiotic administration.</p></div><div><h3>Results</h3><p>Nineteen cases of antibiotic resistance involving hirudotherapy were identified. Only three cases of antibiotic resistance were discovered on routine testing and the remaining 16 cases were associated with patient injury. Positive blood cultures or fever were present in 26.3 % (<em>n</em> = 5) of cases. Cultures of the infection grew Aeromonas hydrophilia (<em>n</em> = 13; 68.4 %), <em>Vibrio vulnificus</em> (<em>n</em> = 3; 15.8 %), <em>Pseudomonas aeruginosa</em> (<em>n</em> = 2; 10.5 %), and <em>Proteus vulgaris</em> (<em>n</em> = 1; 5.3 %). There were nine (47.4 %) multi-drug resistant infections. Infection was most commonly resistant to fluoroquinolones (<em>n</em> = 9; 47.4 %), trimethoprim-sulfamethoxazole (n = 9; 47.4 %) and ertapenem (<em>n</em> = 4; 21.1 %).</p></div><div><h3>Conclusion</h3><p>Antibiotic-resistant infections involving hirudotherapy are frequently resistant to multiple drugs, including fluoroquinolones and trimethoprim-sulfamethoxazole. Resistance to ertapenem, a drug of last resort, was also documented. The findings presented in this study support growing literature that the trend in multi-drug resistance is more severe than previously reported.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104500"},"PeriodicalIF":1.8,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142087878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The influence of tinnitus frequency on patients experiencing subjective tinnitus and the efficacy and prognosis of acoustic therapy 耳鸣频率对主观性耳鸣患者的影响以及声学疗法的疗效和预后
IF 1.8 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-14 DOI: 10.1016/j.amjoto.2024.104498
Juan Li, Yu Zhang, Yuqin Chen, Songli Xi, Song Shi, Cong Li, Tiantian Su

Objective

This study examines the therapeutic impact and prognosis of acoustic therapy in patients with chronic subjective tinnitus across different tinnitus frequencies.

Methods

A total of 135 patients with subjective tinnitus were selected and categorized based on their primary tone frequency into three groups: high frequency (43 patients, 4–8 kHz), mid frequency (40 patients, 1–3 kHz), and low frequency (42 patients, < 1 kHz). All patients received acoustic therapy customized to their specific frequency and loudness levels, along with tinnitus cognitive behavioral therapy. Changes in tinnitus loudness and efficacy rates before and after treatment in the different groups, as well as before and after tinnitus cognitive behavioral therapy were evaluated and assessed.

Results

The low frequency group showed a statistical improvement in tinnitus loudness compared to the mid and high frequency groups (P < 0.05). The efficacy rate was 93.55 % in the low frequency group, 82.88 % in the mid frequency group, and 58.82 % in the high frequency group. The efficacy rate in the low frequency group was significantly higher than in the high frequency group, but there was no statistical difference when compared to the mid frequency group.

Conclusion

The frequency of tinnitus in patients with chronic subjective tinnitus might be a key factor affecting treatment effectiveness and could account for the differences in treatment outcomes among patients.

本研究探讨了声学疗法对不同耳鸣频率的慢性主观性耳鸣患者的治疗效果和预后。方法共选取了135名主观性耳鸣患者,根据他们的主音频率分为三组:高频组(43名患者,4-8 kHz)、中频组(40名患者,1-3 kHz)和低频组(42名患者,< 1 kHz)。所有患者都接受了针对其特定频率和响度水平的声学疗法,以及耳鸣认知行为疗法。结果与中频和高频组相比,低频组的耳鸣响度有统计学改善(P <0.05)。低频组的有效率为 93.55%,中频组为 82.88%,高频组为 58.82%。低频组的有效率明显高于高频组,但与中频组相比无统计学差异。
{"title":"The influence of tinnitus frequency on patients experiencing subjective tinnitus and the efficacy and prognosis of acoustic therapy","authors":"Juan Li,&nbsp;Yu Zhang,&nbsp;Yuqin Chen,&nbsp;Songli Xi,&nbsp;Song Shi,&nbsp;Cong Li,&nbsp;Tiantian Su","doi":"10.1016/j.amjoto.2024.104498","DOIUrl":"10.1016/j.amjoto.2024.104498","url":null,"abstract":"<div><h3>Objective</h3><p>This study examines the therapeutic impact and prognosis of acoustic therapy in patients with chronic subjective tinnitus across different tinnitus frequencies.</p></div><div><h3>Methods</h3><p>A total of 135 patients with subjective tinnitus were selected and categorized based on their primary tone frequency into three groups: high frequency (43 patients, 4–8 kHz), mid frequency (40 patients, 1–3 kHz), and low frequency (42 patients, &lt; 1 kHz). All patients received acoustic therapy customized to their specific frequency and loudness levels, along with tinnitus cognitive behavioral therapy. Changes in tinnitus loudness and efficacy rates before and after treatment in the different groups, as well as before and after tinnitus cognitive behavioral therapy were evaluated and assessed.</p></div><div><h3>Results</h3><p>The low frequency group showed a statistical improvement in tinnitus loudness compared to the mid and high frequency groups (<em>P</em> &lt; 0.05). The efficacy rate was 93.55 % in the low frequency group, 82.88 % in the mid frequency group, and 58.82 % in the high frequency group. The efficacy rate in the low frequency group was significantly higher than in the high frequency group, but there was no statistical difference when compared to the mid frequency group.</p></div><div><h3>Conclusion</h3><p>The frequency of tinnitus in patients with chronic subjective tinnitus might be a key factor affecting treatment effectiveness and could account for the differences in treatment outcomes among patients.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104498"},"PeriodicalIF":1.8,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142040271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individualized sublingual immunotherapy with dynamic maintenance dose ascending for house dust mite-induced allergic rhinitis 针对屋尘螨诱发的过敏性鼻炎,采用动态维持剂量递增的个性化舌下免疫疗法。
IF 1.8 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-13 DOI: 10.1016/j.amjoto.2024.104476
Juan Wang , Ling Cai , Caiqin Huang , Jing Pei, Xinyi Shi, Yuejin Tao

Background

Precision dosing in sublingual immunotherapy (SLIT) has become a hotspot gradually, yet no standardized dose adjustment pattern for house dust mite (HDM)-SLIT. This study aims to investigate the clinical feasibility of the dynamic maintenance dose ascending regimen for individualized SLIT.

Methods

A total of 258 allergic rhinitis (AR) patients treated with HDM-SLIT were included in this retrospective study. Patients were divided into the regular dose (RD) group (n = 101) and the high dose (HD) group (n = 157) according to different maintenance dosages of SLIT. In the RD group, patients received the fixed dose recommended by the manufacturer. In the HD group, patients received a maximum tolerance dose determined by dynamic dose ascending. The clinical efficacy was evaluated by combined symptom and medication score (CSMS) and visual analogue scale score (VAS) at the baseline, 0.5-year, 1-year, and 2-year. The safety was evaluated by adverse events (AEs).

Results

Significant reductions of CSMS and VAS at 0.5-year, 1-year, and 2-year were observed in both the RD group and the HD group compared to the baseline (P < 0.05). In addition, greater improvements in these clinical parameters from 0.5- to 2-year were found in the HD group compared to the RD group (P < 0.05). For subgroup analysis in the HD group, no significant differences in CSMS and VAS were observed among subgroups of patients <14 years old and patients ≥14 years old (P > 0.05). No serious AEs in the two groups and no significant differences were observed between the AE incidence rate of the RD group and HD group during the incremental and maintenance phases.

Conclusions

The 2-year HDM-SLIT with dynamic maintenance dose ascending regimen offers an “optimal” treatment for AR patients while maintaining safety. This study introduced a pattern for individualized dose adjustment in clinical practice, offering potential benefits for AR patients.

背景:舌下免疫疗法(SLIT)的精确剂量逐渐成为热点,但目前尚无针对屋尘螨(HDM)-SLIT的标准化剂量调整模式。本研究旨在探讨个体化舌下免疫疗法动态维持剂量递增方案的临床可行性:这项回顾性研究共纳入了 258 名接受 HDM-SLIT 治疗的过敏性鼻炎(AR)患者。根据 SLIT 的不同维持剂量,患者被分为常规剂量(RD)组(n = 101)和高剂量(HD)组(n = 157)。在常规剂量组,患者接受生产商推荐的固定剂量。在高剂量组,患者接受的是动态剂量递增法确定的最大耐受剂量。临床疗效通过基线、0.5 年、1 年和 2 年的症状和用药综合评分(CSMS)和视觉模拟量表评分(VAS)进行评估。安全性通过不良事件(AEs)进行评估:与基线相比,RD 组和 HD 组在 0.5 年、1 年和 2 年的 CSMS 和 VAS 均显著下降(P 0.05)。在递增阶段和维持阶段,两组均未出现严重的AE,RD组和HD组的AE发生率也无明显差异:为期2年的HDM-SLIT动态维持剂量递增方案为AR患者提供了 "最佳 "治疗,同时保证了安全性。这项研究在临床实践中引入了个体化剂量调整模式,为 AR 患者带来了潜在的益处。
{"title":"Individualized sublingual immunotherapy with dynamic maintenance dose ascending for house dust mite-induced allergic rhinitis","authors":"Juan Wang ,&nbsp;Ling Cai ,&nbsp;Caiqin Huang ,&nbsp;Jing Pei,&nbsp;Xinyi Shi,&nbsp;Yuejin Tao","doi":"10.1016/j.amjoto.2024.104476","DOIUrl":"10.1016/j.amjoto.2024.104476","url":null,"abstract":"<div><h3>Background</h3><p>Precision dosing in sublingual immunotherapy (SLIT) has become a hotspot gradually, yet no standardized dose adjustment pattern for house dust mite (HDM)-SLIT. This study aims to investigate the clinical feasibility of the dynamic maintenance dose ascending regimen for individualized SLIT.</p></div><div><h3>Methods</h3><p>A total of 258 allergic rhinitis (AR) patients treated with HDM-SLIT were included in this retrospective study. Patients were divided into the regular dose (RD) group (<em>n</em> = 101) and the high dose (HD) group (<em>n</em> = 157) according to different maintenance dosages of SLIT. In the RD group, patients received the fixed dose recommended by the manufacturer. In the HD group, patients received a maximum tolerance dose determined by dynamic dose ascending. The clinical efficacy was evaluated by combined symptom and medication score (CSMS) and visual analogue scale score (VAS) at the baseline, 0.5-year, 1-year, and 2-year. The safety was evaluated by adverse events (AEs).</p></div><div><h3>Results</h3><p>Significant reductions of CSMS and VAS at 0.5-year, 1-year, and 2-year were observed in both the RD group and the HD group compared to the baseline (<em>P</em> &lt; 0.05). In addition, greater improvements in these clinical parameters from 0.5- to 2-year were found in the HD group compared to the RD group (<em>P</em> &lt; 0.05). For subgroup analysis in the HD group, no significant differences in CSMS and VAS were observed among subgroups of patients &lt;14 years old and patients ≥14 years old (<em>P</em> &gt; 0.05). No serious AEs in the two groups and no significant differences were observed between the AE incidence rate of the RD group and HD group during the incremental and maintenance phases.</p></div><div><h3>Conclusions</h3><p>The 2-year HDM-SLIT with dynamic maintenance dose ascending regimen offers an “optimal” treatment for AR patients while maintaining safety. This study introduced a pattern for individualized dose adjustment in clinical practice, offering potential benefits for AR patients.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104476"},"PeriodicalIF":1.8,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between blood transfusion and outcomes of free flap head and neck cancer surgery 输血与游离头颈癌皮瓣手术疗效之间的关系
IF 1.8 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-13 DOI: 10.1016/j.amjoto.2024.104497
Kenzo M. Cotton , Andrew R. Mangan , James R. Gardner , Aryan Shay , Deanne King , Emre A. Vural , Mauricio Moreno-Vera , Geoffrey Muller , Jumin Sunde

Objective

Investigate the impact of patient risk factors and blood transfusions in Head and Neck free flap surgeries.

Study design

Retrospective chart review.

Setting

Single tertiary referral center.

Methods

400 patients were included undergoing free flap reconstruction from 2014 to 2020. The primary outcome measures were red blood cell transfusion and volume transfused. Race, sex, flap location and tissue type, pathology, dependent functional status, length of stay, and cancer recurrence were evaluated for association with red blood cell transfusion intraoperatively and/or postoperatively. Transfusions were indicated on patients with Hemoglobin <7–8 and/or symptomatic anemia. ANOVA and Chi2 statistical analysis were performed. The significance was set at p ≤0.05.

Results

Of the 400 patients included, 58 required red blood cell transfusion. Of these 67.8 % were males, racial demographics included 9.00 % African American, 1.30 % Asian, 1.00 % Hispanic/Latino, 87.8 % White, 1.00 % other. African American patients received a higher volume of transfused red blood cells versus white patients (855.00 mL vs. 437.07 mL, p = 0.005). Length of stay was significantly associated with red blood cell transfusion (5.95 days vs. 7.22 days, p ≤0.001). Dependent functional status and need for red blood cell transfusion were associated (p = 0.002). Type of free flap was associated with need for red blood cell transfusion (p ≤0.001) with anterolateral thigh flaps being the most common resulting in transfusion (34/58).

Conclusion

Red blood cell transfusion was significantly associated with race, dependent functional status and length of stay. Certain free flaps have a higher risk of blood transfusion.

研究设计回顾性病历审查。方法纳入2014年至2020年期间接受游离皮瓣重建术的400名患者。主要结果指标为红细胞输注量和输血量。评估种族、性别、皮瓣位置和组织类型、病理、依赖功能状态、住院时间和癌症复发与术中和/或术后输注红细胞的关系。输血适用于血红蛋白为 7-8 和/或有症状的贫血患者。进行了方差分析和Chi2统计分析。结果 在纳入的 400 名患者中,58 人需要输注红细胞。其中 67.8% 为男性,种族人口统计学特征包括 9.00% 非裔美国人、1.30% 亚洲人、1.00% 西班牙/拉丁美洲人、87.8% 白人、1.00% 其他。与白人患者相比,非裔美国人患者输注的红细胞量更高(855.00 mL vs. 437.07 mL,p = 0.005)。住院时间与输注红细胞明显相关(5.95 天 vs. 7.22 天,p ≤0.001)。依赖性功能状态与输注红细胞的需求相关(p = 0.002)。游离皮瓣的类型与输注红细胞的需求有关(p≤0.001),其中大腿前外侧皮瓣是最常见的导致输血的皮瓣(34/58)。某些游离皮瓣的输血风险较高。
{"title":"Association between blood transfusion and outcomes of free flap head and neck cancer surgery","authors":"Kenzo M. Cotton ,&nbsp;Andrew R. Mangan ,&nbsp;James R. Gardner ,&nbsp;Aryan Shay ,&nbsp;Deanne King ,&nbsp;Emre A. Vural ,&nbsp;Mauricio Moreno-Vera ,&nbsp;Geoffrey Muller ,&nbsp;Jumin Sunde","doi":"10.1016/j.amjoto.2024.104497","DOIUrl":"10.1016/j.amjoto.2024.104497","url":null,"abstract":"<div><h3>Objective</h3><p>Investigate the impact of patient risk factors and blood transfusions in Head and Neck free flap surgeries.</p></div><div><h3>Study design</h3><p>Retrospective chart review.</p></div><div><h3>Setting</h3><p>Single tertiary referral center.</p></div><div><h3>Methods</h3><p>400 patients were included undergoing free flap reconstruction from 2014 to 2020. The primary outcome measures were red blood cell transfusion and volume transfused. Race, sex, flap location and tissue type, pathology, dependent functional status, length of stay, and cancer recurrence were evaluated for association with red blood cell transfusion intraoperatively and/or postoperatively. Transfusions were indicated on patients with Hemoglobin &lt;7–8 and/or symptomatic anemia. ANOVA and Chi<sup>2</sup> statistical analysis were performed. The significance was set at <em>p</em> ≤0.05.</p></div><div><h3>Results</h3><p>Of the 400 patients included, 58 required red blood cell transfusion. Of these 67.8 % were males, racial demographics included 9.00 % African American, 1.30 % Asian, 1.00 % Hispanic/Latino, 87.8 % White, 1.00 % other. African American patients received a higher volume of transfused red blood cells versus white patients (855.00 mL vs. 437.07 mL, <em>p</em> = 0.005). Length of stay was significantly associated with red blood cell transfusion (5.95 days vs. 7.22 days, <em>p</em> ≤0.001). Dependent functional status and need for red blood cell transfusion were associated (<em>p</em> = 0.002). Type of free flap was associated with need for red blood cell transfusion (<em>p</em> ≤0.001) with anterolateral thigh flaps being the most common resulting in transfusion (34/58).</p></div><div><h3>Conclusion</h3><p>Red blood cell transfusion was significantly associated with race, dependent functional status and length of stay. Certain free flaps have a higher risk of blood transfusion.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104497"},"PeriodicalIF":1.8,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141992855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A lightweight intelligent laryngeal cancer detection system for rural areas 适用于农村地区的轻型智能喉癌检测系统
IF 1.8 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-08 DOI: 10.1016/j.amjoto.2024.104474
Yi-Fan Kang , Lie Yang , Kai Xu , Bin-Bin Hu , Lan-Jun Cai , Yin-Hao Liu , Xiang Lu

Objective

Early diagnosis of laryngeal cancer (LC) is crucial, particularly in rural areas. Despite existing studies on deep learning models for LC identification, challenges remain in selecting suitable models for rural areas with shortages of laryngologists and limited computer resources. We present the intelligent laryngeal cancer detection system (ILCDS), a deep learning-based solution tailored for effective LC screening in resource-constrained rural areas.

Methods

We compiled a dataset comprised of 2023 laryngoscopic images and applied data augmentation techniques for dataset expansion. Subsequently, we utilized eight deep learning models—AlexNet, VGG, ResNet, DenseNet, MobileNet, ShuffleNet, Vision Transformer, and Swin Transformer—for LC identification. A comprehensive evaluation of their performances and efficiencies was conducted, and the most suitable model was selected to assemble the ILCDS.

Results

Regarding performance, all models attained an average accuracy exceeding 90 % on the test set. Particularly noteworthy are VGG, DenseNet, and MobileNet, which exceeded an accuracy of 95 %, with scores of 95.32 %, 95.75 %, and 95.99 %, respectively. Regarding efficiency, MobileNet excels owing to its compact size and fast inference speed, making it an ideal model for integration into ILCDS.

Conclusion

The ILCDS demonstrated promising accuracy in LC detection while maintaining modest computational resource requirements, indicating its potential to enhance LC screening accuracy and alleviate the workload on otolaryngologists in rural areas.

目标喉癌(LC)的早期诊断至关重要,尤其是在农村地区。尽管目前已有关于喉癌识别深度学习模型的研究,但在为喉科医生短缺和计算机资源有限的农村地区选择合适的模型方面仍存在挑战。我们提出了智能喉癌检测系统(ILCDS),这是一种基于深度学习的解决方案,专为资源有限的农村地区提供有效的喉癌筛查。随后,我们使用了八种深度学习模型--AlexNet、VGG、ResNet、DenseNet、MobileNet、ShuffleNet、Vision Transformer 和 Swin Transformer--进行喉癌识别。结果在性能方面,所有模型在测试集上的平均准确率都超过了 90%。特别值得一提的是,VGG、DenseNet 和 MobileNet 的准确率超过了 95%,分别为 95.32%、95.75% 和 95.99%。在效率方面,MobileNet 由于体积小、推理速度快而表现出色,是集成到 ILCDS 中的理想模型。
{"title":"A lightweight intelligent laryngeal cancer detection system for rural areas","authors":"Yi-Fan Kang ,&nbsp;Lie Yang ,&nbsp;Kai Xu ,&nbsp;Bin-Bin Hu ,&nbsp;Lan-Jun Cai ,&nbsp;Yin-Hao Liu ,&nbsp;Xiang Lu","doi":"10.1016/j.amjoto.2024.104474","DOIUrl":"10.1016/j.amjoto.2024.104474","url":null,"abstract":"<div><h3>Objective</h3><p>Early diagnosis of laryngeal cancer (LC) is crucial, particularly in rural areas. Despite existing studies on deep learning models for LC identification, challenges remain in selecting suitable models for rural areas with shortages of laryngologists and limited computer resources. We present the intelligent laryngeal cancer detection system (ILCDS), a deep learning-based solution tailored for effective LC screening in resource-constrained rural areas.</p></div><div><h3>Methods</h3><p>We compiled a dataset comprised of 2023 laryngoscopic images and applied data augmentation techniques for dataset expansion. Subsequently, we utilized eight deep learning models—AlexNet, VGG, ResNet, DenseNet, MobileNet, ShuffleNet, Vision Transformer, and Swin Transformer—for LC identification. A comprehensive evaluation of their performances and efficiencies was conducted, and the most suitable model was selected to assemble the ILCDS.</p></div><div><h3>Results</h3><p>Regarding performance, all models attained an average accuracy exceeding 90 % on the test set. Particularly noteworthy are VGG, DenseNet, and MobileNet, which exceeded an accuracy of 95 %, with scores of 95.32 %, 95.75 %, and 95.99 %, respectively. Regarding efficiency, MobileNet excels owing to its compact size and fast inference speed, making it an ideal model for integration into ILCDS.</p></div><div><h3>Conclusion</h3><p>The ILCDS demonstrated promising accuracy in LC detection while maintaining modest computational resource requirements, indicating its potential to enhance LC screening accuracy and alleviate the workload on otolaryngologists in rural areas.</p></div>","PeriodicalId":7591,"journal":{"name":"American Journal of Otolaryngology","volume":"45 6","pages":"Article 104474"},"PeriodicalIF":1.8,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141964555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Otolaryngology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1